Collaboration enables real-time data collection and analysis from the
physician and pharmacy throughout the patient journey; promises to
deliver unprecedented transparency on medication selection and patient
outcomes across many diseases and conditions

LA JOLLA, Calif.–(BUSINESS WIRE)–Trio Health announced today that Accredo Specialty Pharmacy will
collaborate with Trio Health on their proprietary technology and
analytics platform to provide real world evidence of outcomes on a wide
range of medicines. The collaboration is expected to bring unprecedented
value-based transparency to a medication’s journey.

“Our healthcare system is comprised of patients, pharmaceutical
companies, payers, physicians, pharmacy benefits managers and
pharmacies, all with differing interests in terms of innovation, pricing
and access to care. The ability to evaluate a complete data set
encompassing patient experience and outcomes enables unparalleled
insight into medication selection and value, insight that has been
missing from our healthcare system,” said Brent Clough, CEO of Trio
Health. “We believe once these factors become clearer, patients and
biopharma innovators will benefit, as payers adopt a true
performance-based model for drug reimbursement.”

Continued Mr. Clough, “Our collaboration with Accredo enables us to
expand on our experience analyzing real world evidence in evaluating
treatments for hepatitis C, oncology, RA, hemophilia and HIV, and review
medications covering a broad range of diseases and conditions that are
prescribed to millions of patients and cost billions of dollars.”

Trio Health has the ability to analyze pharmacy, physician, and clinical
information within its proprietary database. The resultant patient
de-identified data is harmonized to bring a new understanding of the
delivery, use and outcomes of prescription medications while optimizing
care of real world patients.

About Trio Health

Trio Health’s mission is to improve the quality of care in patient
outcomes through coordinating the efforts of all patient care
stakeholders. Their first-of-its-kind Multi-Disease Platform (MDX) that
tracks patients throughout the course of their treatment, giving
pharmaceutical/biotechnology companies, specialty pharmacies and
physicians access to information and opportunities that simply don’t
exist anywhere else. Learn more at www.triohealth.com.

Contacts

For Trio Health
Brad Miles
Solebury Trout
646-513-3125
[email protected]